Crossbow Therapeutics, Inc
Christine Devlin is a Senior Scientist at Crossbow Therapeutics, Inc, with a background in Biochemistry. Christine also has experience as a Graduate Research Assistant at the University of Illinois at Urbana-Champaign and George Washington University. Christine's technical skills include RNA/DNA/protein isolation, western blotting, RT-qPCR, mammalian tissue culture, and bioinformatics software. Christine has also worked as a Teaching Assistant and Research Assistant, demonstrating their versatility in laboratory settings. Additionally, Christine has experience in customer service as a Sales Associate and medical internships in phlebotomy.
Crossbow Therapeutics, Inc
Crossbow Therapeutics, Inc., is a biotechnology company determined to improve the lives of people with cancer by unlocking the therapeutic potential of T-cell receptor (TCR)-mimetic antibodies. The company’s T-Bolt™ therapies are next-generation, easily assembled immunotherapies directed with high precision at previously unreachable cancer cell targets. Crossbow’s efficient and selective approach is designed to target the entire universe of cancer proteins, dramatically expanding the potential of antibody therapy to address many types of cancer.